PHARVARIS NV
PHVS · NASDAQ
Updated at 2026-10-15 07:53:16
- Today's High
- $30.52
- Today’s Low
- $29.80
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $30.00
- Previous Close
- $30.02
- Volume
- 400.42K
- Market Cap
- $2.09B
- P/E Ratio
- --
- EPS
- $-2.61
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- GRAFENAUWEG 8, ZUG, SWITZERLAND, 6300
- Country
- NL
- Listing Date
- 2021-02-05
- Fiscal Year End
- December
- Shares Outstanding
- 69.67M
- CIK
- 0001830487
- Website
- pharvaris.com
Pharvaris NV, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of rare disease therapies. The company is headquartered in Leiden, the Netherlands.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$50.78M
2026-03-31
$44.89M
2025-12-31
$47.59M
2025-09-30
$39.66M
Net Income
2026-06-30
-$47.84M
2026-03-31
-$39.84M
2025-12-31
-$46.74M
2025-09-30
-$37.13M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.81
2026-03-31
$-0.71
2025-12-31
$-0.71
2025-09-30
$-0.60
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$50.6M
2026-03-31
-$39.37M
2025-12-31
-$47.49M
2025-09-30
-$37.21M
Effective Tax Rate
2026-06-30
-1.27%
2026-03-31
-0.7%
2025-12-31
--
2025-09-30
0.48%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $50.78M | $44.89M | $47.59M | $39.66M |
| Net Income | -$47.84M | -$39.84M | -$46.74M | -$37.13M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.81 | $-0.71 | $-0.71 | $-0.60 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$50.6M | -$39.37M | -$47.49M | -$37.21M |
| Effective Tax Rate | -1.27% | -0.7% | -- | 0.48% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.